Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systematic review

Author： Mok C. C.  

Publisher： Informa Healthcare

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.36, Iss.5, 2007-01, pp. : 329-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus

By Weng Meng-Yu   Weng Chia-Tse   Liu Ming-Fei  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 771-775

Springer Publishing Company

Access to resources Recommend Favorite

Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review

By Mattos Priscila   Santiago Mittermayer  

Clinical Rheumatology, Vol. 30, Iss. 2, 2011-02 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

Off-label use of rituximab in systemic lupus erythematosus: a systematic review

By Murray Eleanor   Perry Martin  

Clinical Rheumatology, Vol. 29, Iss. 7, 2010-07 ,pp. : 707-716

Springer Publishing Company

Access to resources Recommend Favorite

Central Nervous System Manifestations in Systemic Lupus Erythematosus

By  

Current Rheumatology Reviews, Vol. 3, Iss. 3, 2007-08 ,pp. : 205-214

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular and Pulmonary Manifestations of Systemic Lupus Erythematosus

By  

Current Rheumatology Reviews, Vol. 13, Iss. 3, 2017-12 ,pp. : 206-218

Bentham Science Publishers

Access to resources Recommend Favorite